Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gerrard

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Leukemia|August 27, 2010
Analysis of BCR-ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotypeH Grant, X Jiang, J Stebbing, et al.
Leukemia|March 13, 2019
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.
Leukemia|January 16, 2020
Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.
Leukemia|April 26, 2016
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International ScaleN C P Cross, H E White, T Ernst, et al.
Leukemia|July 19, 2014
A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCRH White, L Deprez, P Corbisier, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Leukemia|August 27, 2010
Analysis of BCR-ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotypeH Grant, X Jiang, J Stebbing, et al.
Leukemia|March 13, 2019
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.
Leukemia|January 16, 2020
Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.
Leukemia|April 26, 2016
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International ScaleN C P Cross, H E White, T Ernst, et al.
Leukemia|July 19, 2014
A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCRH White, L Deprez, P Corbisier, et al.
Pageof 4